-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MM5z2UIDX5lm3MkZZMVmhPnaeU7PaoWEQtmPTfzQvBSE9p+yU/72zm6BaaPwp1U6 hCpA1LzFZu6+y7o77nqK6Q== 0001181431-05-065317.txt : 20051207 0001181431-05-065317.hdr.sgml : 20051207 20051207194639 ACCESSION NUMBER: 0001181431-05-065317 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051205 FILED AS OF DATE: 20051207 DATE AS OF CHANGE: 20051207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGE LOUIS G CENTRAL INDEX KEY: 0001238401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21643 FILM NUMBER: 051250663 BUSINESS ADDRESS: BUSINESS PHONE: 6503848500 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94034 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CV THERAPEUTICS INC CENTRAL INDEX KEY: 0000921506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 431570294 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3172 PORTER DR CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6503848500 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 rrd99326.xml X0202 4 2005-12-05 0 0000921506 CV THERAPEUTICS INC CVTX 0001238401 LANGE LOUIS G 3172 PORTER DRIVE PALO ALTO CA 94304 1 1 0 0 Chairman & CEO Common Stock, $0.001 par value per share ("Common Stock") 107198 D Common Stock 1488.8935 I By 401(k) Common Stock 2500 I By others in household Common Stock 7500 I By Trust Nonstatutory Stock Option (right to buy) 24.94 2005-12-05 4 A 0 36000 0 A 2006-12-05 2015-12-05 Common Stock 36000 36000 D Restricted Stock Units 2005-12-05 4 A 0 48000 0 A 2006-12-31 2009-12-31 Common Stock 48000 48000 D Includes 1,926 shares acquired on February 17, 2005 pursuant to the CV Therapeutics, Inc. Employee Stock Purchase Plan. Shares held in the Reporting Person's name by the Issuer's 401(k) plan. Shares held by (i) persons living in the same household as the Reporting Person and/or (ii) minors living in the same houshold as the Reporting Person. Shares held by the Louis Lange Family Trust. Dr. Lange disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Twenty percent (20%) of the shares subject to the option vest on December 5, 2006. The remaining shares vest at the rate of 1.667% of the shares subject to the option per month for the next 24 months and at the rate of 3.333% of the shares subject to the option for the next 12 months. Upon payout, Reporting Person is entitled to receive 1 share of common stock for each 1 restricted stock unit. Vests in four (4) successive equal annual installments of twenty-five percent (25%) each upon Reporting Person's completion of each year of service over the four (4) - year period measured from December 5, 2005. Vested shares are distributed on each vesting date. Tricia Borga Suvari, Attorney-in-Fact for: Louis G Lange 2005-12-07 -----END PRIVACY-ENHANCED MESSAGE-----